EE507 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer Unselected for DDR Mutations
| Autor: | Niyazov, A., Simou, E., Kirker, M., Houghton, K., Le Moine, J.G., Chang, J., Yarr, S., Barnett, C., Mladsi, D.D. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S149-S149 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect